C. Falcon

The platelet insulin receptor: detection, partial characterization, and search for a function.

H. Deckmyn, J. Vermylen, C. Falcón, 1988, Biochemical and biophysical research communications.

Inhibition of human platelet aggregation and thromboxane-B2 production by melatonin: evidence for a diurnal variation.

D. Cardinali, L. Carreras, M. M. Del Zar, 1990, The Journal of clinical endocrinology and metabolism.

Clinical Significance of Various ELISA Assays for Detecting Antiphospholipid Antibodies

L. Carreras, C. Falcón, A. Hoffer, 1990, Thrombosis and Haemostasis.

Detection of Lupus-Like Anticoagulants by an Enzyme-Linked Immunosorbent Assay Using a Partial Thromboplastin as Antigen; A Comparative Study

J. Vermylen, J. Arnout, C. Falcón, 1990, Thrombosis and Haemostasis.

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.

P. Mannucci, I. Martinelli, P. Mannucci, 1997, Circulation.

High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

P. Mannucci, I. Martinelli, P. Mannucci, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Pregnancy Loss and Autoantibodies Against Phospholipid‐Binding Proteins

L. Carreras, M. Martinuzzo, C. Falcón, 1997, Obstetrics and gynecology.

R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin

H. Deckmyn, J. Vermylen, C. Falcón, 1990 .

R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin.

H. Deckmyn, J. Vermylen, C. Falcón, 1990, Blood.